NewsSOS
Pomerantz LLP, a law firm specializing in securities litigation, announced Tuesday it is investigating claims on behalf of investors of Omeros Corporation, a company trading on the Nasdaq exchange under the ticker symbol OMER.
The New York-based firm has invited affected shareholders to come forward as it examines potential legal claims against the biopharmaceutical company.
Scope of the Investigation Pomerantz LLP disclosed the investigation in a release dated July 1, 2026, without specifying the nature of the underlying claims or the time period under review.
The firm did not identify any particular transactions, corporate disclosures, or events that triggered the inquiry. Investors holding positions in Omeros Corporation are the primary subjects of the firm's outreach.
Keep reading